Expedited Review claims are paid the current Payment Percentage of the Scheduled Value for each disease as outlined in the TDP. Expedited Review is also intended to provide qualifying claimants a fixed and certain claim payment.  The current Payment Percentage is 60%.

Halliburton or Non-Harbison-Walker Entity Claims

Disease LevelScheduled Value
Mesothelioma  (Level VIII)
$58,933.22
Lung Cancer 1 (Level VII)
$9,581.80
Other Cancer  (Level V)
$8,242.41
Severe Asbestosis  (Level IV)
$9,684.83
Asbestosis/Pleural Disease (Level III)
$2,472.72
Asbestosis/Pleural Disease (Level II)
$1,133.33
Other Asbestos Disease (Level I)
$103.03

 

Harbison-Walker Entity Claims

Disease LevelScheduled Value
Mesothelioma (Level VIII)
$140,636.09
Lung Cancer 1 (Level VII)
$46,260.51
Other Cancer (Level V)
$24,727.22
Severe Asbestosis (Level IV)
$30,393.88
Asbestosis/Pleural Disease (Level III)
$7,418.17
Asbestosis/Pleural Disease (Level II)
$3,915.14
Other Asbestos Disease (Level I)
$309.09